🔗 Permalink

Inventor profile of:

Dieter Moosmayer

City:

Berlin

Country:

Germany

Published Applications:

16

Last publication date:

2024-03-14

Top Assignees for applications by Dieter Moosmayer

The entities that hold a legal rights for patent applications filed by inventor Moosmayer Dieter:

Bayer Pharma Aktiengesellschaft 8 Berlin, Germany
Bayer Aktiengesellschaft 3 Leverkusen, Germany
Bayer HealthCare LLC 2 Whippany, NJ United States
BIONTECH AG 1 Mainz, Germany
THE BROAD INSTITUTE, INC. 1 Cambridge, MA United States
Dana-Farber-Cancer Institute, Inc. 1 Boston, MA United States
Bayer Healthcare China 1 Beijing, China
BioNTech AG 1 , Germany

Recent patent applications by Moosmayer Dieter

Dieter Moosmayer from Berlin, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-03-14

US20240083857A1

Chemistry; metallurgy

2-Methyl-Quinazolines

#2 | 2022-09-01

US20220274979A1

Chemistry; metallurgy

2-METHYL-AZA-QUINAZOLINES

#3 | 2022-07-28

US20220235013A1

Chemistry; metallurgy

2-METHYL-QUINAZOLINES

#4 | 2022-07-21

US20220227729A1

Chemistry; metallurgy

IDENTIFICATION AND USE OF KRAS INHIBITORS

#5 | 2022-05-24

US16758018

Chemistry; metallurgy

4H-pyrrolo[3,2-c]pyridin-4-one derivatives

#6 | 2022-02-10

US20220041752A1

Chemistry; metallurgy

MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)

#7 | 2020-12-10

US20200383991A1

Human necessities

2-(morpholin-4-yl)-1,7-naphthyridines

#8 | 2019-05-30

US20190160048A1

Human necessities

Substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-A]pyridine-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-C][1,2,4]triazol-3-ones, and use thereof

#9 | 2018-09-13

US20180256591A1

Human necessities

2-(morpholin-4-yl)-1,7-naphthyridines

#10 | 2018-07-12

US20180194857A1

Chemistry; metallurgy

MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)

#11 | 2017-08-03

US20170216304A1

Human necessities

2-(morpholin-4-yl)-1,7-naphthyridines

#12 | 2017-04-20

US20170107298A1

Chemistry; metallurgy

MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)

#13 | 2016-10-06

US20160287604A1

Human necessities

2-(morpholin-4-yl)-1,7-naphthyridines

#14 | 2015-06-04

US20150152186A1

Chemistry; metallurgy

Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZe (antibody-mediated apoptosis inducing cytokines)

#15 | 2015-03-17

US10389223

Performing operations; transporting

Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZEe (antibody-mediated apoptosis inducing cytokines)

#16 | 2014-10-02

US20140294832A1

Chemistry; metallurgy

MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)

InventorID:

920704 ⎘